Agenda: Optimizing Patient Selection & Prediction of Therapy Efficacy in Clinical Trials with ctDNA

Tuesday, June 14

6:00 pm Doors Open – Registration & Welcome Reception

6:30 pm Opening Remarks & Introduction

6:35 pm Interactive Panel Discussion & Q&A: Trends & Opportunities for ctDNA in Clinical Trials

Synopsis

• Hear biopharma and academic perspectives on key challenges in oncology drug development that ctDNA seeks to address
• Discuss how ctDNA has been used to stratify and enrich for clinical trial cohorts and support early assessment of therapy efficacy today, and how this is expected to evolve in the future
• Evaluate opportunities to leverage ctDNA to support program prioritization, secure additional funding, and optimize clinical trial design

7:15 pm Networking & Drinks

Synopsis

Informal and exclusive opportunity to engage with senior pharma leaders and researchers interested in ctDNA and oncology clinical trial innovations

8:00 pm End of Natera Engager